The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Boots Ibuprofen and Codeine 200mg / 12.8 mg film-coated tablets



Taw Pharma (Ireland) LimitedPA23081/004/001

Main Information

Trade NameBoots Ibuprofen and Codeine 200mg / 12.8 mg film-coated tablets
Active SubstancesIbuprofen
Codeine phosphate hemihydrate
Dosage FormFilm-coated tablet
Licence HolderTaw Pharma (Ireland) Limited
Licence NumberPA23081/004/001

Group Information

ATC CodeN02AJ Opioids in combination with non-opioid analgesics
N02AJ08 codeine and ibuprofen

Status

License statusWithdrawn
Withdrawn Date20/05/2024
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceProduct not subject to medical prescription, supply through pharmacies only and promotion to the healthcare professionals only subject to the following restrictions: For ibuprofen: maximum strength 200 mg, maximum pack size 50, maximum dose 400 mg, maximum daily dose 1200 mg, limited indications. For use in adults: children not under 12 years Product not subject to medical prescription, supply through pharmacies only subject to the following restrictions for codeine: maximum dose 20 mg.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back